The Chancellor, Masters And Scholars Of The University Of Oxford investment portfolio

DARK BLUE THERAPEUTICS LTD is a biotechnology company that discovers and develops precision oncology therapies. The company focuses on creating innovative medicines that exploit novel cancer vulnerabilities, with a lead program targeting MLLT1/3 degraders for acute myeloid leukemia and certain solid tumors.

FRACTILE LTD develops in-memory computing chips designed to accelerate AI inference, aiming to make large AI models run significantly faster, cheaper, and more energy-efficiently than current hardware. The company targets enterprises and organizations deploying advanced AI models that require high-performance, low-latency processing for complex workloads like autonomous coding, scientific research, and sophisticated chatbots.